An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.

NCT03998696 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Cisplatin 40 mg/m2
DRUG: Cisplatin 100 mg/m2

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh